期刊文献+

慢性心力衰竭患者6min步行试验与血清脑利钠肽水平的临床研究 被引量:21

Clinical study on the six-minute walk test and serum brain natriuretic peptide levels in patients with chronic heart failure
暂未订购
导出
摘要 目的 :通过对慢性心力衰竭患者的 6min步行试验 (6MWT)的距离和血清脑利钠肽 (BNP)水平的观察 ,探讨 6MWT和BNP水平对心力衰竭患者心脏功能评估的临床意义。方法 :测量 5 1例慢性心力衰竭患者 (心衰组 )的 6MWT距离和酶联免疫吸附法检测血清BNP 32浓度。并以 30例健康成人为对照组。结果 :心衰组的 6MWT距离 380 .3± 12 1.7m明显低于对照组 5 46 .8± 12 8.5m (P <0 .0 1)。心衰组BNP水平 75 8.3± 2 89.5ng·L-1明显高于对照组10 9.3± 37.6ng·L-1(P <0 .0 1)。NYHA心功能Ⅱ级的 6MWT距离 4 2 5 .0± 10 5 .8m明显低于Ⅲ级335 .6± 12 6 .1m (P <0 .0 1)。NYHAⅡ级的BNP水平 6 38.5± 2 2 4 .5ng·L-1明显高于Ⅲ级 878.0±334.0ng·L-1(P <0 .0 1)。 6MWT距离 <30 0、30 0~374 .9、375~ 4 49.9和 <4 5 0m患者的BNP水平分别为 988.9± 2 0 2 .6、76 8.6± 2 17.4、6 5 7.5± 185 .0和5 0 6 .9± 198.4ng·L-1(P <0 .0 1) ;6MWT的距离与BNP水平呈负相关 (r =- 0 .75 2 ,P <0 .0 1)。结论 :6MWT和BNP水平测定对慢性心力衰竭患者的心脏功能评估具有重要临床意义。 AIM: To investigate clinical significance of Six-Minute Walk Test (6MWT) and serum brain natriuretic peptide (BNP) levels in evaluating heart function in patients with chronic heart failure (CHF). METHODS: 51 patients with CHF (CHF group) and 30 healthy subjects served as control group were involved in the trials. The distance walked in six-minute and the serum levels of BNP-32 by enzyme-linked immunosorbent assay method were observed. The differences among 6MWT distance,BNP levels and different NYHA classes were analysed. RESULTS: The 6MWT distances in CHF group and control group were 380.3 ± 121.7 and 546.8 ± 128.5 m ,respectively (P< 0.01 ). The serum levels of BNP in CHF group and control group were 758.3 ± 289.5 and 109.3 ± 37.6 ng·L -1 ,respectively (P< 0.01 ). The 6MWT distances in NYHA classⅡand Ⅲ of CHF patients were 425.0 ± 105.8 and 335.6 ± 126.1 m ,respectively (P< 0.01 ). The BNP levels in NYHA classⅡand Ⅲ of CHF patients were 638.5 ± 224.5 and 878.0 ± 334.0 ng·L -1 ,respectively (P< 0.01 ). BNP levels in CHF patients of 6MWT distances among below 300,300- 374.9 ,375- 449.9 and above 450 m was 988.9 ± 202.6 , 768.6 ± 217.4 , 657.5 ± 185.0 and 506.9 ± 198.4 ng·L -1 ,respectively (P< 0.01 ). The 6MWT distance was inversely correlated to the BNP level (r=- 0.752 ,P< 0.01 ). CONCLUSION: Not only 6MWT distances but also serum BNP levels have an important clinical value in evaluating heart function of CHF.
出处 《中国临床药理学与治疗学》 CAS CSCD 2004年第5期561-564,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 心力衰竭 6分钟步行试验 利钠肽 诊断 心脏功能评估 heart failure six-minute walk test brain natriuretic peptide diagnosis heart function evaluation
  • 相关文献

参考文献13

  • 1慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2410
  • 2Maisel AS;Krishnaswamy P;Nowak RM;McCord J, Hollander JE, Duc P.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J],2002(03).
  • 3Harrison A;Morrison LK;Krishnaswamy P;Kazanegra R, Clopton P, Dao Q.B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J],2002(02).
  • 4陈协兴,洪华山,王一波,江琼,董现锋,陈良龙.慢性心力衰竭患者血清脑利钠肽水平的变化及其临床意义[J].中国临床药理学与治疗学,2003,8(6):631-634. 被引量:12
  • 5陈协兴,洪华山,王一波,江琼,陈良龙.脑钠素在慢性心力衰竭诊断、预后评估中的价值[J].中国循环杂志,2003,18(6):434-436. 被引量:17
  • 6Guyatt GH;Sullivan MJ;Thompson PJ.The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure,1985(08).
  • 7Bittner V;Weiner DH;Yusuf S.Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigtors[J],1993(14).
  • 8Peeters P;Mets T.The 6-minute walk as appropriate exercise test in elderly patients with chronic heart failure,1996(04).
  • 9Cahalin LP;Mathier MA;Semigran MJ;Dec GW,DiSalvo TG.The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure[J],1996(02).
  • 10McDonagh TA;Robb SD;Murdoch DR;Morton JJ, Ford I, Morrison CE.Biochemical detection of left ventricular systolic dysfunction[J],1998(9095).

二级参考文献10

  • 1邢云利 贾三庆.BNP可作为心衰诊断和预后的新指标[J].中国医学论坛报,2002,28:14-14.
  • 2[1]Maeda K,Tsutamota T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J,1998,135 : 825-832.
  • 3[2]Maisel AS,Krishnaswamy P, Richards M, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002,347:161-167.
  • 4[3]Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet, 1998,351:9-13.
  • 5[5]Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels . Jpn Heart J, 2000,41: 205-214.
  • 6[6]Cowie MW.BNP: soon to become a routine measure in the care of patients with heart failure? Heart,2000,83:617-618.
  • 7[7]Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med, 2002, 39: 131-138.
  • 8[8]Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriureric peptide in cardiology.J Lab Clin Med, 1999, 134:437-444.
  • 9Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
  • 10慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2410

共引文献2436

同被引文献158

引证文献21

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部